• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens.

作者信息

Kucharczyk Aleksandra, Marczyk Katarzyna, Kucharczyk Barbara, Plisko Robert, Perkowska Jolanta, Owczarek Witold, Jahnz-Różyk Karina

机构信息

Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.

Medical Faculty I, Medical University of Warsaw, Warszawa, Poland.

出版信息

Allergy. 2024 Sep;79(9):2554-2557. doi: 10.1111/all.16194. Epub 2024 Jun 24.

DOI:10.1111/all.16194
PMID:38922945
Abstract
摘要

相似文献

1
Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens.预测慢性自发性荨麻疹的复发：一项评估奥马珠单抗撤药方案的回顾性队列研究。
Allergy. 2024 Sep;79(9):2554-2557. doi: 10.1111/all.16194. Epub 2024 Jun 24.
2
Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹皮肤外症状的疗效
Eur J Dermatol. 2021 Feb 1;31(1):86-87. doi: 10.1684/ejd.2020.3717.
3
Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria.奥马珠单抗治疗与慢性诱导性荨麻疹相关的慢性自发性荨麻疹的疗效
Ann Allergy Asthma Immunol. 2020 Oct;125(4):486-487. doi: 10.1016/j.anai.2020.06.011. Epub 2020 Jun 13.
4
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
5
The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort.在西澳大利亚门诊队列中，奥马珠单抗治疗难治性慢性自发性荨麻疹的应用。
Intern Med J. 2019 Apr;49(4):526-528. doi: 10.1111/imj.14245.
6
Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.奥马珠单抗用于“复杂”患者的慢性自发性荨麻疹：来自真实临床实践的数据
Drug Des Devel Ther. 2019 Sep 6;13:3181-3186. doi: 10.2147/DDDT.S214307. eCollection 2019.
7
Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment.奥马珠单抗治疗的慢性自发性荨麻疹患者复发的潜在临床和血清学预测因素
Immunotherapy. 2020 Nov;12(16):1173-1181. doi: 10.2217/imt-2020-0088. Epub 2020 Sep 7.
8
Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with chronic urticaria.慢性荨麻疹患者长期日常实践队列中奥马珠单抗药物留存率的决定因素
Allergy. 2019 Jun;74(6):1185-1187. doi: 10.1111/all.13714. Epub 2019 Jan 25.
9
H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab.对于难治性慢性自发性荨麻疹患者，在开始使用奥马珠单抗后，H1抗组胺药可能不再必要。
J Investig Allergol Clin Immunol. 2020 Apr 24;30(2):145-147. doi: 10.18176/jiaci.0464. Epub 2019 Nov 25.
10
Real-world dosing of omalizumab for chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹的真实世界用药情况。
Ann Allergy Asthma Immunol. 2020 Feb;124(2):211-212. doi: 10.1016/j.anai.2019.11.028. Epub 2019 Dec 2.

引用本文的文献

1
Vitamin D and skin disorders: bridging molecular insights to clinical innovations.维生素D与皮肤疾病：将分子见解与临床创新相联系
Mol Med. 2025 Jul 18;31(1):259. doi: 10.1186/s10020-025-01311-5.
2
Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria.奥马珠单抗治疗慢性自发性荨麻疹期间ELR、PLR、NLR和BLR比率的评估
J Clin Med. 2024 Jul 23;13(15):4287. doi: 10.3390/jcm13154287.